Identifying responders and nonresponders to interferon therapy in multiple sclerosis

Interferon beta is a well established disease-modifying agent used for relapsing-remitting multiple sclerosis. Despite treatment, a relevant proportion of patients continue to experience clinical (ie, relapses, worsening of disability) and magnetic resonance imaging (MRI) activity. Early identificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperini, Luca, Capobianco, Marco, Giannì, Costanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2014
Materias:
Degenerative Neurological and Neuromuscular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337239/
https://www.ncbi.nlm.nih.gov/pubmed/32669902
http://dx.doi.org/10.2147/DNND.S42734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337239/
https://www.ncbi.nlm.nih.gov/pubmed/32669902
http://dx.doi.org/10.2147/DNND.S42734

Ejemplares similares